INHIBITION OF P38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS
申请人:Dumas Jacques
公开号:US20120046290A1
公开(公告)日:2012-02-23
This invention relates to the use of a group of aryl ureas in treating cytokine mediated diseases, other than cancer and proteolytic enzyme mediated diseases, other than cancer, and pharmaceutical compositions for use in such therapy.
route for the C―S coupling of aryl halides with thiophenols is described. This method is tolerant to electron‐withdrawing and electron‐donating functional groups and also to the presence of functional groups in the ortho position of the aryl iodide or thiophenol. Aryl iodides are coupled with thiophenols without affecting the other functionalities present in the aryl ring. These reactions follow second‐order
nanoparticles have been studied for C−N, C−O, and C−S bond formations via cross-couplingreactions of nitrogen, oxygen, and sulfur nucleophiles with aryl halides. Amides, amines, imidazoles, phenols, alcohols and thiols undergo reactions with aryl iodides in the presence of a base such as KOH, Cs2CO3, and K2CO3 at moderate temperature. The procedure is simple, general, ligand-free, and efficient to afford the
通过氮,氧和硫亲核试剂与芳基卤化物的交叉偶联反应,已研究了CuO纳米颗粒的C-N,C-O和C-S键形成。酰胺,胺,咪唑,酚,醇和硫醇在中等温度下在碱(例如KOH,Cs 2 CO 3和K 2 CO 3)存在下与芳基碘化物反应。该过程简单,通用,无配体且有效地以高收率提供了交叉偶联的产物。
Efficient Copper(I)-Catalyzed C–S Cross Coupling of Thiols with Aryl Halides in Water